NCT06348303View on ClinicalTrials.gov

Study to Assess Drowsiness, Cognition, Fall Risk After Metaxalone 640 mg and Metaxalone 800 mg

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 16, 2024

Primary Completion Date

September 5, 2024

Study Completion Date

October 30, 2024

Conditions
Healthy Participants
Interventions
DRUG

Metaxalone m640 mg oral tablet

Metaxalone partially micronized 640 mg tablet

DRUG

Metaxalone 800 mg oral tablet

Metaxalone non-micronized 800 mg oral tablet

Trial Locations (1)

43213

ClinOhio Research Institute, Columbus

Sponsors
All Listed Sponsors
collaborator

ClinOhio Research Services, LLC

INDUSTRY

lead

Primus Pharmaceuticals

INDUSTRY